How do prices of drugs for weight loss in the U.S. compare to peer nations’ prices?

https://www.healthsystemtracker.org/brief/prices-of-drugs-for-weight-loss-in-the-us-and-peer-nations/?utm_campaign=morning_rounds&utm_medium=email&_hsmi=270760454&_hsenc=p2ANqtz-_MFqA3hHYYdwSq7s0jrf8b1gTE55qqi52JXWlQCan9uATDxIqpxhuEadvKEfIiAFkYvBoqrEZPJTsf2fSNOiOaraw3tQ&utm_content=270760453&utm_source=hs_email Wildly popular weight loss drugs are hard to find. They’re also expensive. A new KFF analysis compares list prices for the drugs in the U.S. to those in similar countries. Prices are much higher here for the drugs, also prescribed for diabetes, even though obesity is more prevalent in the U.S. (33.6%) than in other high-income nations (17.1%). A previous KFF poll found that about half of U.S. adults were interested in taking the drugs until they learned insurance might not pay and the weight might come back. Two price checks: Ozempic, approved in the U.S. for diabetes, is more than five times as expensive in the U.S. ($936) as in the next costliest nation, Japan ($169). Wegovy, approved in the U.S. for weight loss, is four times as expensive in the U.S. ($1,349) as in Germany ($328). KFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs https://www.kff.org/health-costs/poll-finding/kff-health-tracking-poll-july-2023-the-publics-views-of-new-prescription-weight-loss-drugs-and-prescription-drug-costs/